SERUM AND URINE SOLUBLE INTERLEUKIN-2 RECEPTOR IN IDIOPATHIC NEPHROTIC SYNDROME

被引:30
|
作者
BOCK, GH
ONGKINGCO, JR
PATTERSON, LT
RULEY, J
SCHROEPFER, LR
NELSON, DL
机构
[1] Immunophysiology Section, Metabolism Branch, DCBDC, National Cancer Institute, Bethesda, Maryland
[2] Department of Nephrology, Children's National Medical Center, Washington, District of Columbia, 20010
[3] Department of Pediatrics, George Washington University School of Medicine, Washington, District of Columbia
[4] Howard Hughes Medical Institute-National Institutes of Health Research Scholars Program, Bethesda, Maryland
关键词
MINIMAL CHANGE NEPHROTIC SYNDROME; PATHOGENESIS; INTERLEUKIN-2; RECEPTOR; URINE AND SERUM;
D O I
10.1007/BF00852533
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Although a cellular immune pathogenesis is suspected in idiopathic nephrotic syndrome of childhood (INS), there is scant direct evidence of in vivo immune activation. In order to investigate cytokine cascade activation in INS, soluble interleukin-2 receptor (sIL-2R) in plasma and urine was characterized and its levels measured in INS patients during relapse. Immunochemically detectable sIL-2R had a molecular mass of 35-46 kDa in both serum and urine and the molecule appears to be excreted intact; the pI was 5.05. INS patients had elevated serum sIL-2R levels compared with adult normal controls (845 +/- 97 vs. 373 +/- 47 U/ml, P = 0.001) and were significantly higher than previously published age-matched controls. Urinary excretion of sIL-2R was 47.2 +/- 13 U/mg creatinine in patients. Both the sIL-2R excretion rate and the fractional excretion of sIL-2R were positively correlated with the excretion of albumin (P = 0.02 and 0.002, respectively). These increased serum and urine levels occurred whether relapse was or was not associated with an intercurrent illness. We conclude that: (1) despite increased sIL-2R excretion during INS relapse, serum levels are significantly elevated; (2) while the elevated urinary levels could result from enhanced intrarenal production, they more likely reflect the increased serum levels; (3) the elevated sIL-2R levels support an immune pathogenesis in INS.
引用
收藏
页码:523 / 528
页数:6
相关论文
共 50 条
  • [41] SERUM LEVELS OF SOLUBLE INTERLEUKIN-2 RECEPTOR IN SYSTEMIC AND CIRCUMSCRIBED SCLERODERMA
    ZILLIKENS, D
    BLUM, C
    DUMMER, R
    HARTMANN, AA
    BURG, G
    DERMATOLOGY, 1992, 184 (03) : 233 - 234
  • [42] Serum soluble interleukin-2 receptor levels in familial Mediterranean fever
    Erken, E
    Gunesacar, R
    Ozbek, S
    Konca, K
    ANNALS OF THE RHEUMATIC DISEASES, 1996, 55 (11) : 852 - 855
  • [43] Serum levels of soluble interleukin-2 receptor in renal cell carcinoma
    Matsumoto, T
    Furukawa, A
    Sumiyoshi, Y
    Akiyama, KY
    Kanayama, HO
    Kagawa, S
    UROLOGY, 1998, 51 (01) : 145 - 149
  • [44] The serum concentration of soluble interleukin-2 receptor in patients with Kawasaki disease
    Teraura, Hiroyuki
    Kotani, Kazuhiko
    Minami, Takaomi
    Takeshima, Taro
    Shimooki, Osamu
    Kajii, Eiji
    ANNALS OF CLINICAL BIOCHEMISTRY, 2017, 54 (02) : 209 - 213
  • [45] SOLUBLE INTERLEUKIN-2 RECEPTOR IN SERUM OF PATIENTS WITH ESOPHAGEAL-CARCINOMA
    JABLONSKA, E
    KOZLOWSKI, M
    PIETRUSKA, Z
    FURMAN, M
    NEOPLASMA, 1994, 41 (06) : 315 - 318
  • [46] EFFECT OF ANTITUMOR SURGERY ON SOLUBLE INTERLEUKIN-2 RECEPTOR SERUM LEVELS
    BRIVIO, F
    LISSONI, P
    MANCINI, D
    TISI, E
    TANCINI, G
    BARNI, S
    NOCITI, V
    AMERICAN JOURNAL OF SURGERY, 1991, 161 (04): : 466 - 469
  • [47] Soluble interleukin-2 receptor serum levels facilitate prediction of relapses in subgroups of patients with juvenile idiopathic arthritis
    Ziegler, Linda
    Fuehner, Sabrina
    Kessel, Christoph
    Hinze, Claas
    Klotsche, Jens
    Niewerth, Martina
    Minden, Kirsten
    Foell, Dirk
    RHEUMATOLOGY, 2022, 61 (12) : 4975 - 4984
  • [48] SERUM LEVELS OF SOLUBLE INTERLEUKIN-2 RECEPTOR IN PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS AND SYSTEMIC IDIOPATHIC VASCULITIS
    DANIELI, MG
    PAOLETTI, P
    RECCHIONI, A
    GABRIELLI, A
    DANIELI, G
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 1993, 22 (05) : 215 - 219
  • [49] THE EFFECT OF AZATHIOPRINE ON SERUM LEVELS OF INTERLEUKIN-6 AND SOLUBLE INTERLEUKIN-2 RECEPTOR
    CRILLY, A
    MCINNES, IB
    CAPELL, HA
    MADHOK, R
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 1994, 23 (02) : 87 - 91
  • [50] Plasma soluble interleukin-2 receptor levels in patients with idiopathic thrombocytopenic purpura
    Erduran, E
    Aslan, Y
    Aliyazicioglu, Y
    Mocan, H
    Gedik, Y
    AMERICAN JOURNAL OF HEMATOLOGY, 1998, 57 (02) : 119 - 123